1. Test–retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial. Issue 6 (22nd October 2018) Authors: Newitt, David C.; Zhang, Zheng; Gibbs, Jessica E.; Partridge, Savannah C.; Chenevert, Thomas L.; Rosen, Mark A.; Bolan, Patrick J.; Marques, Helga S.; Aliu, Sheye; Li, Wen; Cimino, Lisa; Joe, Bonnie N.; Umphrey, Heidi; Ojeda‐Fournier, Haydee; Dogan, Basak; Oh, Karen; Abe, Hiroyuki; Drukteinis, Je... Journal: Journal of magnetic resonance imaging Issue: Volume 49:Issue 6(2019) Page Start: 1617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patients. Issue 3 (April 2023) Authors: Dotan, Efrat; Catalano, Paul; Lenchik, Leon; Boutin, Robert; Yao, Xin; Marques, Helga S.; Ioffe, Dina; Zhen, David B.; Li, Daneng; Wagner, Lynne I.; Simon, Melissa A.; Wong, Terence Z.; O'Dwyer, Peter J. Journal: Journal of geriatric oncology Issue: Volume 14:Issue 3(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗